Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market
The Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market size was valued at US$ 816.0 Mn in 2021 and is projected to reach US$ 1,870.3 Mn by 2028, growing at a CAGR of 12.6% during 2021 - 2028.
Report Coverage
- Organization Size: Small and Medium Organizations and Large Organizations
- Offerings: Products, Platforms, Services
- Application: Product Design and Discovery, Product Development, Pre-Clinical Targeting, Assessment of Drugs and Other Biomedical Products
- Clinical Indication: Cardiovascular Diseases, Neurodegenerative Diseases, Oncology, Rare Diseases, Metabolic Diseases, Immune Based Diseases, Infectious Diseases
- End User: Pharmaceutical and Biopharmaceutical Companies, Medical Technology Companies, Contract Research Organizations
US$ 816.0 Mn
Market size in 2021
US$ 1,870.3 Mn
Market Size by 2028
12.6%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Regional Analysis
6.2 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue 2019-2028 (US$ Million)
6.3 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Forecast Analysis
7. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Analysis – by Organization Size
7.1 Small and Medium Organizations and Large Organizations
- 7.1.1 Overview
- 7.1.2 Small and Medium Organizations and Large Organizations: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Analysis – by Offerings
8.1 Products
- 8.1.1 Overview
- 8.1.2 Products: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Platforms
- 8.2.1 Overview
- 8.2.2 Platforms: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Services
- 8.3.1 Overview
- 8.3.2 Services: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Analysis – by Application
9.1 Product Design and Discovery
- 9.1.1 Overview
- 9.1.2 Product Design and Discovery: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Product Development
- 9.2.1 Overview
- 9.2.2 Product Development: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Pre-Clinical Targeting
- 9.3.1 Overview
- 9.3.2 Pre-Clinical Targeting: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Assessment of Drugs and Other Biomedical Products
- 9.4.1 Overview
- 9.4.2 Assessment of Drugs and Other Biomedical Products: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Analysis – by Clinical Indication
10.1 Cardiovascular Diseases
- 10.1.1 Overview
- 10.1.2 Cardiovascular Diseases: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.2 Neurodegenerative Diseases
- 10.2.1 Overview
- 10.2.2 Neurodegenerative Diseases: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.3 Oncology
- 10.3.1 Overview
- 10.3.2 Oncology: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.4 Rare Diseases
- 10.4.1 Overview
- 10.4.2 Rare Diseases: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.5 Metabolic Diseases
- 10.5.1 Overview
- 10.5.2 Metabolic Diseases: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.6 Immune Based Diseases
- 10.6.1 Overview
- 10.6.2 Immune Based Diseases: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.7 Infectious Diseases
- 10.7.1 Overview
- 10.7.2 Infectious Diseases: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)
11. Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Europe Analysis
11.1 Overview
11.2 Europe- 11.2.1 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Key Country, 2022 and 2028 (%)
- 11.2.1.1 Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 UK: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 UK: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
- 11.2.1.1.2 UK: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
- 11.2.1.1.3 UK: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application
- 11.2.1.1.4 UK: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Clinical Indication
- 11.2.1.2 Germany: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Germany: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
- 11.2.1.2.2 Germany: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
- 11.2.1.2.3 Germany: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application
- 11.2.1.2.4 Germany: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Clinical Indication
- 11.2.1.3 France: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 France: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
- 11.2.1.3.2 France: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
- 11.2.1.3.3 France: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application
- 11.2.1.3.4 France: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Clinical Indication
- 11.2.1.4 Russia: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.4.1 Russia: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
- 11.2.1.4.2 Russia: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
- 11.2.1.4.3 Russia: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application
- 11.2.1.4.4 Russia: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Clinical Indication
- 11.2.1.5 Italy: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.5.1 Italy: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
- 11.2.1.5.2 Italy: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
- 11.2.1.5.3 Italy: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application
- 11.2.1.5.4 Italy: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Clinical Indication
- 11.2.1.6 Rest of Europe: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.6.1 Rest of Europe: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
- 11.2.1.6.2 Rest of Europe: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
- 11.2.1.6.3 Rest of Europe: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application
- 11.2.1.6.4 Rest of Europe: Europe In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Clinical Indication
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 InSilicoTrials Technologies
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Feops
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 CADFEM Medical GmbH
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Dassault Systèmes SE
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Virtonomy GmbH
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Certara Inc.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Computational Life
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 NOVA
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 TwInsight Medical
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Ansys, Inc.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Synopsys, Inc.
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
14.12 Sensyne Health plc.
- 14.12.1 Key Facts
- 14.12.2 Business Description
- 14.12.3 Products and Services
- 14.12.4 Financial Overview
- 14.12.5 SWOT Analysis
- 14.12.6 Key Developments
14.13 Cerner Corporation
- 14.13.1 Key Facts
- 14.13.2 Business Description
- 14.13.3 Products and Services
- 14.13.4 Financial Overview
- 14.13.5 SWOT Analysis
- 14.13.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
